Navigation Links
Anti-Retroviral Therapies Associated with Reduced Infections in HIV-Infected Children

Since the introduction of highly active antiretroviral therapies, there has been a substantial reduction of opportunistic infections and other infections in HIV-infected children,// such as pneumonia and tuberculosis, according to a study.

The human immunodeficiency virus (HIV) epidemic has spurred the development of new antiretroviral, immune, and vaccine-based therapies geared to block transmission, prevent disease progression, and prolong the survival of individuals who are HIV positive, according to background information in the article. Highly active antiretroviral therapy (HAART) has dramatically decreased rates of AIDS-related opportunistic infections (infections caused by an organism capable of causing disease in a host whose resistance is lowered, e.g., by other diseases or by drugs) and deaths in adults. Although HAART has dramatically decreased illness and death in HIV-infected infants, children, and adolescents in the United States, no studies comparing the incidence of opportunistic and other related infections before and during the HAART era have been conducted.

Philimon Gona, Ph.D., of the Harvard School of Public Health and Boston University, Boston, and colleagues estimated the rates for the first occurrence of 29 targeted opportunistic and other related infections between Jan. 1, 2001, and Dec. 31, 2004, in HIV-infected infants, children, and adolescents to compare the rates in the HAART era to those of the pre-HAART era. The study included 2,767 children enrolled between Sept. 15, 2000, and Dec. 31, 2004, with information entered in the database up to August 1, 2005, when data analysis was conducted. The pre-HAART era comparison population included 3,331 children enrolled in 13 Pediatric AIDS Clinical Trials Group (PACTG) protocols from October 1988 to August 1998.

Seventy-five percent of the children were enrolled in 2000 and 2001. Overall, 553 first episodes of a specific infection occurred among 395 (14 percen t) of the study participants. The incidence rates (IRs) per 100 person-years for the 4 most common first-time infections were bacterial pneumonia (IR, 2.15), herpes zoster (IR, 1.11), dermatophyte infections (IR, 0.88), and oral candidiasis (IR, 0.93). Infection rates were significantly lower than those reported in the PACTG in the pre-HAART era: bacterial pneumonia (IR, 11.1), bacteremia (IR, 3.3), herpes zoster (IR, 2.9), oral candidiasis (IR, 1.2) and tuberculosis (IR, 0.2).

“Despite these current advances due to HAART, some HIV-infected children continue to develop opportunistic infections. Some children fail to respond to antiretroviral therapy as a result of viral resistance, poor adherence, or inability to tolerate complex treatment regimens. Furthermore, prophylactic [preventive] therapies are not fully effective and poor adherence can further reduce their efficacy. Drug interactions, complex dosing schedules, adverse effects, and high costs can further limit the efficacy of these therapies. Although these issues do present challenges, our findings demonstrate a substantial reduction in the incidence of several opportunistic infections in HIV-infected children since the introduction of HAART therapy,” the authors write.

(Source: Newswise)

Related medicine news :

1. Anti-Retrovirals in Africa, not a distant dream
2. Anti-Retrovirals Capable of Halting Mental Illness in HIV Patients
3. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
4. Preventive Therapies Found to be More Effective in Managing Migraines
5. Ayurvedic Therapies Cashing In On Medical Tourism
6. Immune-Boosting Therapies Of No Use In Preventing Miscarriage
7. Non Hormonal Therapies for Menopause Not Proved to be Effective
8. Need for More Talking Therapies for Treating Depression
9. Are Alternative Therapies A Reliable Alternative?
10. Special Behavioral Therapies made Women more likely to Attempt Suicide
11. Alternative Therapies May Not Ease Menopause Symptoms
Post Your Comments:

(Date:11/25/2015)... , ... November 25, 2015 , ... Many people know ... fuzzy-headedness, weight gain, cold hands, and dry skin. But many people who find their ... and exercise regimen instead of their thyroid, especially if they don’t have any of ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... offering lower prices in an early celebration of the early holiday shopping season. ... of $29.95 each (normally $33.95 ea). Black Friday promotional pricing is in addition ...
(Date:11/24/2015)... ... November 24, 2015 , ... New patients who wish to seek treatment ... dental implants at her Mississauga, ON practice. Dr. Williams has been providing dental ... dental implants. , Missing teeth can lead to a variety of complications if ...
(Date:11/24/2015)... ... 2015 , ... In an article published November 12th by Obesity ... are or are not eligible for bariatric surgery. The article explains that candidates for ... than 100 pounds overweight, or have a BMI of 35 and over with at ...
(Date:11/24/2015)... ... November 24, 2015 , ... Preparing for the LDT Regulation:, CLIA Won’t ... , FDA has long asserted that design and manufacture of Laboratory ... tests and do not meet the device regulations. , Come up short in an ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... -- Sectra (STO: SECT B) announces that ... multi-year agreement to deploy Breast Imaging PACS in ... the Breast Center a future-proof platform capable of expanding with ... announces that Breast Center of Acadiana has entered ... PACS in its two freestanding imaging centers. This investment will ...
(Date:11/24/2015)... , November 24, 2015 ... --> adds Latest Guidebook for Chinese ... 217 pages published in November 2015 to the ... business intelligence library at . ... the fastest growing global economies with a fifth ...
(Date:11/24/2015)... F1000Workspace - a research collaboration, ... was launched just six months ago. --> F1000Workspace ... for scientists - since it was launched just six months ... on to F1000Workspace - a research collaboration, reference ... launched just six months ago. --> ...
Breaking Medicine Technology: